Oxford-AstraZeneca COVID-19 Vaccine To Be Tested On Children For First Time
(Reuters) – Oxford University has launched a study to assess the safety and immune response of the COVID-19 vaccine developed with AstraZeneca PLC in children for the first time, it said on Saturday.
The new mid-stage test will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an email from the university.
Oxford said about 300 volunteers would be enrolled this month and expected to first inoculation.
The two-dose Oxford / AstraZeneca vaccine has been distinguished as the “vaccine for the world” because it is cheaper and easier to find than some rivals.
AstraZeneca aims to produce 3 billion doses this year and more than 200 million doses every month by April.
A HuffPost Guide for Cornaviruses
As COVID-19 cases increase, it is more important to stay connected and informed. Join the Halfpost community today. (It’s free!)